HistoIndex to debut FibroSIGHT™ Plus and showcase latest scientific findings at AASLD The Liver Meeting® 2025

The latest from the Proscia blog Emerging biotechs, along with their small and mid-sized CRO counterparts, are establishing themselves as key players advancing the next generation of therapies. So, in line with our mission to rewire...

OREM, Utah--(BUSINESS WIRE)--Techcyte, a leading provider of AI-powered digital diagnostics for anatomic and clinical pathology, today announced that its platform, Techcyte Fusion™ (research use only (RUO) in the US, CE-IVDD-marked in...

Artera: Novel risk stratification tool advances the frontier of precision oncology by providing access to insights informing critical on-the-ground treatment decisions SAN FRANCISCO--(BUSINESS WIRE)--Artera, the developer of...

Change in Aiforia Technologies Plc’s Management Team Aiforia Technologies Plc, Company release, August 14, 2025 at 9:30 a.m. EEST Thomas Rosqvist (MSc Software Engineering, eMBA) has been appointed as the Chief Technology Officer of...

SINGAPORE, Aug. 11, 2025 /PRNewswire/ -- HistoIndex, a pioneering leader in digital pathology solutions for chronic liver disease, has announced the launch of FibroSIGHT™ Plus, its second Laboratory Developed Test (LDT) available in the...

Indica Labs: Learn about the latest advancements from Indica Labs and how our customers and partners are leveraging image analysis and image management from discovery to diagnostics Indica Labs’ Vienna HALO® User Group...